Professor Olli Kallioniemi (born 1960) is a founder and board member of Sartar Therapeutics. Prof. Kallioniemi received his M.D. degree in 1984 and Ph.D. degree in 1988 at the University of Tampere. Professor Kallioniemi is an expert in a precision medicine. As a founding director of the Institute of Molecular Medicine Finland (FIMM, 2007-2015), he had a crucial role in building a national research infrastructure required for precision medicine research. Now Prof. Kallioniemi is appointed as Director of SciLifeLab, a national center of molecular biosciences organized by Karolinska Institutet, KTH Royal Institute of Technology, Stockholm University and Uppsala University in Sweden. Prof. Kallioniemi has 389 publications that are cited 40,000 times, as well as 20 patents. Prof. Kallioniemi brings to the company invaluable insights on precision medicine strategies and development.